ICON Public Limited (ICLR)
146.65
2.61 (1.81%)
At close: Apr 14, 2025, 3:54 PM
1.81% (1D)
| Bid | 146.16 |
| Market Cap | 11.84B |
| Revenue (ttm) | 8.28B |
| Net Income (ttm) | 791.47M |
| EPS (ttm) | 9.54 |
| PE Ratio (ttm) | 15.37 |
| Forward PE | 14.12 |
| Analyst | Buy |
| Ask | 147.04 |
| Volume | 1,133,823 |
| Avg. Volume (20D) | 1,053,447 |
| Open | 145.05 |
| Previous Close | 144.04 |
| Day's Range | 143.02 - 148.22 |
| 52-Week Range | 138.51 - 347.72 |
| Beta | 1.24 |
About ICLR
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, incl...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date May 15, 1998
Employees 41,900
Stock Exchange NASDAQ
Ticker Symbol ICLR
Website https://www.iconplc.com
Analyst Forecast
According to 12 analyst ratings, the average rating for ICLR stock is "Buy." The 12-month stock price forecast is $205.5, which is an increase of 40.13% from the latest price.
Stock ForecastsNext Earnings Release
ICON Public Limited is scheduled to release its earnings on Apr 30, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-2.74%
Icon shares are trading lower after the company an...
Unlock content with
Pro Subscription
1 month ago
+1.42%
Icon shares are trading higher after the company reported Q4 financial results and beat its adjusted EPS estimate.
